2hon MSN
MindRank in phase 3 trial with China’s first AI-assisted new drug, cutting R&D costs by 60%
The company was aiming for approval in the second half of 2028, paving the way for a market launch in 2029 Hangzhou-based ...
AI launches Grok Enterprise and Business plans, targeting workplace users with higher limits, security controls, and data ...
Introduction Historically, the music industry has been characterised by high barriers to entry, with producing a professional-quality track requiring expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback